首页> 外文期刊>Journal - Oklahoma State Medical Association >Is medical management of Type A intramural hematomas and penetrating aortic ulcers a feasible treatment modality?
【24h】

Is medical management of Type A intramural hematomas and penetrating aortic ulcers a feasible treatment modality?

机译:是intramural血肿和渗透主动脉溃疡的医学管理是可行的治疗方式吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Answer: No. Review of available literature reveals variable outcomes with initial medical management of these types of lesions, particularly intramural hematomas, as 27-96% of medically managed patients with intramural hematomas eventually experience adverse events or require emergency surgical intervention. In 2009, Song et. al reported 84% of patients at their facility with intramural hematomas treated medically had lower in-hospital mortality than similar patients with aortic dissection and equivalent mortality rates to patients with intramural hematoma that were surgically treated.1 Unfortunately, one-third of these medically treated patients progressed to aortic dissection, rupture or aneurysmal degeneration requiring surgical intervention. The subset of subsequently published literature available reveals that aortic intervention is required in approximately 40% of medically managed patients at three years. Given this data, patients with intramural hematomas should be treated similarly to those with aortic dissection in a corresponding location, specifically Type A lesions should be treated with early and aggressive surgical intervention. Patients with penetrating aortic ulcers who are symptomatic or in cases of radiographically proven expansion or contained rupture should undergo definitive treatmentto prevent intramural hematoma formation or progression to aortic dissection.
机译:答:否。可用文献的审查揭示了这些类型病变的初始医学管理的可变结果,特别是历史血肿,27-96%的医学管理患者的历史血肿最终经历不良事件或需要应急外科手术。 2009年,歌曲et。 Al报告了84%的患者在其设施的患者患有医学院治疗的患者患者患者较低的死亡率,而不是在手术治疗的脑室血肿的患者中对具有主动脉抑制和患者的同等性死亡率的患者.1不幸的是,其中三分之一化学治疗患者进入主动脉夹层,破裂或动脉瘤变性需要手术干预。随后公开的文献的子集显示,在三年内,在大约40%的医学患者中需要主动脉干预。鉴于这种数据,患有抗脉络膜血肿的患者应与在相应位置中具有主动脉夹层的人的患者治疗,特别是型病变应使用早期和侵袭性手术干预治疗。患有渗透性溃疡的患者,患者是症状或在射线照相中被证明的扩张或含有破裂的情况下的患者应经过定义治疗,防止脑室血肿形成或进展到主动脉夹层。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号